. . . . . . . "[KRAS mutations were associated with lower response rate to cetuximab plus irinotecan in colorectal cancer patients (4% v 27% in nonmutated patients; P =.021) and shorter PFS (3.0 v 5.3 months; P =.021).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:11+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .